Skip to main content
Clinical Trials/NCT01530321
NCT01530321
Completed
Phase 1

Dose-Response of Manipulation for Cervicogenic Headache

University of Western States2 sites in 1 country256 target enrollmentAugust 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Cervicogenic Headache
Sponsor
University of Western States
Enrollment
256
Locations
2
Primary Endpoint
Headache days change from baseline for cervicogenic headache
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study will determine the number of visits to a chiropractor for spinal manipulation and light massage necessary for the optimal relief of cervicogenic headache (headache with associated neck pain). Effectiveness of care will also be determined.

Registry
clinicaltrials.gov
Start Date
August 2012
End Date
August 2016
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mitchell Haas

Associate Vice President of Research

University of Western States

Eligibility Criteria

Inclusion Criteria

  • chronic cervicogenic headache
  • threshold pain level
  • threshold headache frequency
  • independently ambulatory
  • English literate
  • candidate for spinal manipulation

Exclusion Criteria

  • contraindication to thrust spinal manipulation or massage
  • most other headache types
  • Recent manual/exercise therapy from licensed provider for head/neck
  • threshold pain medication use
  • pregnancy
  • involvement with another pain study
  • suspicion of unmanaged depression
  • most cancers
  • hypertension (at least stage II)
  • complicating neurological/spinal conditions

Outcomes

Primary Outcomes

Headache days change from baseline for cervicogenic headache

Time Frame: 0, 6, 12, 24, 39, 52 weeks

Days with cervicogenic headache in the last four weeks from a daily headache diary. Change score = follow-up score - baseline score)

Secondary Outcomes

  • Outside Care change from baseline(0, 6, 12, 24, 39, 52 weeks)
  • Quality-adjusted life years change from baseline(0, 12, 24, 39, 52 weeks)
  • EuroQol-5D change from baseline(0, 12, 24, 39, 52 weeks)
  • Neck pain days change from baseline(0, 6, 12, 24, 39, 52 weeks)
  • Objective biomechanical measures change from baseline(0, 6 weeks)
  • Headache-related disability days change from baseline(0, 6, 12, 24, 39, 52 weeks)
  • medication use change from baseline(0, 6, 12, 24, 39, 52 weeks)
  • Perceived headache average pain change from baseline for cervicogenic headache(0, 6, 12, 24, 39, 52 weeks)
  • Average pain change from baseline for cervicogenic headache(0, 6, 12, 24, 39, 52 weeks)
  • Headache-related disability change from baseline for cervicogenic headaches(0, 6, 12, 24, 39, 52 weeks)
  • Average pain change from baseline for neck(0, 6, 12, 24, 39, 52 weeks)
  • Patient Satisfaction(week 12)
  • Direct & Indirect costs change from baseline(0, 6, 12, 24, 39, 52 weeks)
  • Perceived headache improvement from baseline for cervicogenic headache(0, 6, 12, 24, 39, 52 weeks)

Study Sites (2)

Loading locations...

Similar Trials